Formic Acid

Formic Acid

SCHEMBL30738145

Nc1nccc2ccccc12.O=CO

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F12 P00748 3/20 0.78
PLAU P00749 2/20 0.78
NCF1 P14598 1/20 0.78
NOS3 P29474 1/20 0.78
NOS1 P29475 1/20 0.78
NOS2 P35228 1/20 0.78
BACE1 P56817 1/20 0.78
ROCK1 Q13464 7/20 0.48
PLG P00747 2/20 0.46
CYP2A6 P11509 1/20 0.46
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
F11 P03951 1/20 0.42
KLKB1 P03952 1/20 0.42
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42
PRSS3 P35030 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL49220 0.88 PLAU (1.00) F12PLAUNCF1NOS3NOS1
SCHEMBL29377365 0.88 PLAU (1.00) F12PLAUNCF1NOS3NOS1
Methylglyoxal SCHEMBL6002250 0.86 F12 (0.68) F12PLAUNCF1NOS3NOS1
Hydrochloric Acid SCHEMBL509104 0.86 PLAU (0.95) F12PLAUNCF1NOS3NOS1
Iodide SCHEMBL29988059 0.86 PLAU (0.95) F12PLAUNCF1NOS3NOS1
SCHEMBL28116864 0.86 PLAU (0.95) F12PLAUNCF1NOS3NOS1
Benzamide SCHEMBL19877173 0.80 PLAU (0.68) F12PLAUNCF1NOS3NOS1
Formic Acid SCHEMBL28681087 0.78 CYP2A6 (0.78) F12PLAUNCF1NOS3NOS1
Quinoline SCHEMBL28251904 0.76 NCF1 (0.75) F12PLAUNCF1NOS3NOS1
Formic Acid SCHEMBL30493146 0.73 KDM4E (0.47) F12PLAUNCF1NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536356-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS Xenon Pharmaceuticals Inc. (CA) 2025-04-16 EP disclosed
WO-2023239729-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS XENON PHARMACEUTICALS INC. (CA) 2023-12-14 WO disclosed